Determining receptor-ligand interaction of human galanin receptor type 3

Neurochemistry International

Volumn 57, Issue 7, 2010, Pages 804-811

  Runesson, Johan ^a   Sollenberg, Ulla E ^a   Jurkowski, Wiktor ^a   Yazdi, Samira ^a   Eriksson, Einar E ^b   Elofsson, Arne ^a   Langel, Ülo ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Docking; Galanin; Galanin receptor type 3; GPCR; HGalR3

Indexed keywords

ARGININE; GALANIN; GALANIN RECEPTOR 3; HISTIDINE; MUTANT PROTEIN; PHENYLALANINE; TYROSINE;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CELL MEMBRANE; CELL SURFACE; COMPUTER MODEL; EXTRACELLULAR SPACE; GENE MUTATION; HUMAN; HUMAN CELL; LIGAND BINDING; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; GALANIN; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; RADIOLIGAND ASSAY; RATS; RECEPTOR, GALANIN, TYPE 3;

ANURA; SCOMBRIDAE;

EID: 77958095618     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.08.018     Document Type: Article

References (36)

1. Ballesteros J.A., Weinstein H. Integrated methods for the construction of three dimensional models and computational probing of structure function relations in G protein-coupled receptors. Methods Neurosci. 1995, 25:366-428.
2. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E. The protein data bank. Nucleic Acids Res. 2000, 28:235-242.
3. Berthold M., Kahl U., Jureus A., Kask K., Nordvall G., Langel Ü., Bartfai T. Mutagenesis and ligand modification studies on galanin binding to its GTP-binding-protein-coupled receptor GalR1. Eur. J. Biochem. 1997, 249:601-606.
4. Borowsky B., Walker M.W., Huang L.Y., Jones K.A., Smith K.E., Bard J., Branchek T.A., Gerald C. Cloning and characterization of the human galanin GALR2 receptor. Peptides 1998, 19:1771-1781.
5. Böhme I., Beck-Sickinger A.G. Illuminating the life of GPCRs. Cell Commun. Signal. 2009, 7:16.
6. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., Choi H.J., Kuhn P., Weis W.I., Kobilka B.K., Stevens R.C. High-resolution crystal structure of an engineered human beta-2 adrenergic G protein-coupled receptor. Science 2007, 318:1258-1265.
7. Church W.B., Jones K.A., Kuiper D.A., Shine J., Iismaa T.P. Molecular modelling and site-directed mutagenesis of human GALR1 galanin receptor defines determinants of receptor subtype specificity. Protein Eng. 2002, 15:313-323.
8. Eswar N., John B., Mirkovic N., Fiser A., Ilyin V.A., Pieper U., Stuart A.C., Marti-Renom M.A., Madhusudhan M.S., Yerkovich B., Sali A. Tools for comparative protein structure modeling and analysis. Nucleic Acids Res 2003, 31:3375-3380.
9. Friesner R.A., Banks J.L., Murphy R.B., Halgren T.A., Klicic J.J., Mainz D.T., Repasky M.P., Knoll E.H., Shelley M., Perry J.K., Shaw D.E., Francis P., Shenkin P.S. Glide: a new approach for rapid. accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 2004, 47:1739-1749.
10. Kask K., Berthold M., Kahl U., Nordvall G., Bartfai T. Delineation of the peptide binding sit of the human galanin receptor. EMBO J 1996, 15:236-244.
11. Kask K., Berthold M., Kahl U., Jureus A., Nordvall G., Langel Ü., Bartfai T. Mutagenesis study on human galanin receptor GalR1 reveals domains involved in ligand binding. Ann N Y Acad Sci 1998, 863:78-85.
12. Konkel M.J., Packiarajan M., Chen H., Topiwala U.P., Jimenez H., Talisman I.J., Coate H., Walker M.W. Amino substituted analogs of 1-phenyl-3-phenylimino-2-indolones with potent galanin Gal3 receptor binding affinity and improved solubility. Bioorg Med Chem Lett 2006, 16:3950-3954.
13. Krogh A., Larsson B., von Heijne G., Sonnhammer E.L. Predicting transmembrane protein topology with a hidden markov model: application to complete genomes. J Mol Biol 2001, 305:567-580.
14. Lang R., Berger A., Santic R., Geisberger R., Hermann A., Herzog H., Kofler B. Pharmacological and functional characterization of galanin-like peptide fragments as potent galanin receptor agonists. Neuropeptides 2005, 39:179-184.
15. Lang R., Gundlach A.L., Kofler B. The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol. Ther 2007, 115:177-207.
16. Lassmann T., Sonnhammer E.L. Kalign-an accurate and fast multiple sequence alignment algorithm. BMC Bioinform. 2005, 6:98.
17. Liu H.X., Brumovsky P., Schmidt R., Brown W., Payza K., Hodzic L., Pou C., Godbout C., Hökfelt T. Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: selective actions via GalR1 and GalR2 receptors. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:9960-9964.
18. Lu X., Lundström L., Langel Ü., Bartfai T. Galanin receptor ligands. Neuropeptides 2005, 39:143-146.
19. Lundström L., Elmquist A., Bartfai T., Langel Ü. Galanin and its receptors in neurological disorders. Neuromol. Med. 2005, 7:157-180.
20. Lundström L., Sollenberg U.E., Bartfai T., Langel Ü. Molecular characterization of the ligand binding site of the human galanin receptor type 2, identifying subtype selective interactions. J. Neurochem. 2007, 103:1774-1784.
21. Melo F., Sali A. Fold assessment for comparative protein structure modeling. Protein Sci. 2007, 16:2412-2426.
22. Melo F., Sanchez R., Sali A. Statistical potentials for fold assessment. Protein Sci. 2002, 11:430-448.
23. Murakami M., Kouyama T. Crystal structure of squid rhodopsin. Nature 2008, 453:363-367.
24. Ohtaki T., Kumano S., Ishibashi Y., Ogi K., Matsui H., Harada M., Kitada C., Kurokawa T., Onda H., Fujino M. Isolation and cDNA cloning of a novel galanin-like peptide (GALP) from porcine hypothalamus. J. Biol. Chem. 1999, 274:37041-37045.
25. Probst W.C., Snyder L.A., Schuster D.I., Brosius J., Sealfon S.C. Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol. 1992, 11:1-20.
26. Robertson C.R., Scholl E.A., Pruess T.H., Green B.R., White H.S., Bulaj G. Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery. J. Med. Chem. 2010, 53:1871-1875.
27. Runesson J., Saar I., Lundström L., Järv J., Langel Ü. A novel GalR2-specific peptide agonist. Neuropeptides 2009, 43:187-192.
28. Runesson J., Robinsson J.K., Sollenberg U.E., Langel Ü. Twenty-five years of galanin research. Bioactive peptides 2009, 237-260. CRC Press, New York. S. Howl, S. Jones (Eds.).
29. Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 1993, 234:779-815.
30. Shen M.Y., Sali A. Statistical potential for assessment and prediction of protein structures. Protein Sci. 2006, 15:2507-2524.
31. Swanson C.J., Blackburn T.P., Zhang X., Zheng K., Xu Z.Q., Hökfelt T., Wolinsky T.D., Konkel M.J., Chen H., Zhong H., Walker M.W., Craig D.A., Gerald C.P., Branchek T.A. Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:17489-17494.
32. Sollenberg U.E., Lundström L., Bartfai T., Langel Ü. M871-a novel peptide antagonist selectively recognizing the galanin receptor type 2. Int. J. Pept. Res. Ther. 2006, 12:115-119.
33. Tatemoto K., Rökaeus A., Jörnvall H., McDonald T.J., Mutt V. Galanin-a novel biologically active peptide from porcine intestine. FEBS Lett. 1983, 164:124-128.
34. Van Durme J., Horn F., Costagliola S., Vriend G., Vassart G. GRIS: glycoprotein-hormone receptor information system. Mol. Endocrinol. 2006, 20:2247-2255.
35. Wang S., He C., Hashemi T., Bayne M. Cloning and expressional characterization of a novel galanin receptor identification of different pharmacophores within galanin for the three galanin receptor subtypes. J. Biol. Chem. 1997, 272:31949-31952.
36. Warne T., Serrano-Vega M.J., Baker J.G., Moukhametzianov R., Edwards P.C., Henderson R., Leslie A.G., Tate C.G., Schertler G.F. Structure of a beta-1 adrenergic G-protein-coupled receptor. Nature 2008, 454:486-491.